Effect of efavirenz on the pharmacokinetics of ketoconazole in HIV-infected patients

By Sriwiriyajan Somchai   Mahatthanatrakul Werawath   Ridtitid Wibool   Jaruratanasirikul Sutep  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 5, 2007-05 ,pp. : 479-483

Springer Publishing Company

Access to resources Recommend Favorite

Antiretroviral Drugs in Pediatric HIV-Infected Patients: Pharmacokinetic and Practical Challenges

By Phelps B. Ryan   Rakhmanina Natella  

Pediatric Drugs, Vol. 13, Iss. 3, 2011-06 ,pp. : 175-192

Adis International

Access to resources Recommend Favorite

Pharmacokinetics and Pharmacodynamics of Low Dose Mycophenolate Mofetil in HIV-Infected Patients Treated with Abacavir, Efavirenz and Nelfinavir

By Millán Olga  

Clinical Pharmacokinetics, Vol. 44, Iss. 5, 2005-01 ,pp. : 525-538

Adis International

Access to resources Recommend Favorite

Influence of tenofovir, nevirapine and efavirenz on ritonavir-boosted atazanavir pharmacokinetics in HIV-infected patients

By Dailly Eric   Tribut Olivier   Tattevin Pierre   Arvieux Cédric   Perré Philippe   Raffi François   Jolliet Pascale  

European Journal of Clinical Pharmacology, Vol. 62, Iss. 7, 2006-07 ,pp. : 523-526

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacokinetic Interactions with Rifampicin: Clinical Relevance

By Niemi M.  

Clinical Pharmacokinetics, Vol. 42, Iss. 9, 2003-01 ,pp. : 819-850

Adis International

Access to resources Recommend Favorite